Skip to main content
Clinical Trials/RBR-2hpkp3
RBR-2hpkp3
Recruiting
未知

Pelvic floor training in the treatment of lower urinary tract symptoms in women with Multiple Sclerosis (MS) and HLTV-I associated Myelopathy (HAM / TSP): A randomized trial

niversidade Federal de Mato Grosso do Sul0 sitesJuly 19, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple sclerosis and Tropical spastic paraparesis in the carrier of T-lymphotropic virus type 1 infection [HTLV-1]
Sponsor
niversidade Federal de Mato Grosso do Sul
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
niversidade Federal de Mato Grosso do Sul

Eligibility Criteria

Inclusion Criteria

  • Women with diagnosis defined in Multiple Sclerosis, in the relapsing remitting form
  • And with the disease stabilized for at least four months, EDSS score less than or equal to 6\.5\. Or women with a diagnosis defined in HAM / TSP, with more than 18 years of age with HTLV \- 1 positive ELISA and confirmed by Western blot (HTLV Blot 2\.4\), with urological and neurological evaluation, Osame Motor Scale dysfunction OMSS) and score in the lower EDSS equal to 6\.5\.
  • Aged over 18years, cognitive ability to respond to evaluation questionnaires and treatment protocol, presenting symptoms of urinary dysfunction for at least six months (at least three of the following: urgency,
  • Urge incontinence, high voiding frequency, nocturia and nocturnal enuresis), with no history of previous treatment with pelvic floor exercises, those that will not present genital prolapses
  • Or history of previous gynecological surgeries that are not pregnant, with no history of vaginal delivery or cesarean section within a period of less than six months prior to the start of the study, as well as those who will be out of menopause and without urinary infection excluded by laboratory examination.

Exclusion Criteria

  • Pregnant women with Diabetes mellitus, indigenous ethnicity and or quilombola, under the age of 18\. Women who present exacerbation of symptoms or outbreak during the course of treatment, those who can not attend the treatment and refuse to perform the proposed treatment or voluntarily give up.

Outcomes

Primary Outcomes

Not specified

Similar Trials